"Tumor Microenvironment" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The milieu surrounding neoplasms consisting of cells, vessels, soluble factors, and molecules, that can influence and be influenced by, the neoplasm's growth.
Descriptor ID |
D059016
|
MeSH Number(s) |
G04.366.500
|
Concept/Terms |
Tumor Microenvironment- Tumor Microenvironment
- Microenvironment, Tumor
- Microenvironments, Tumor
- Tumor Microenvironments
Cancer Microenvironment- Cancer Microenvironment
- Cancer Microenvironments
- Microenvironment, Cancer
- Microenvironments, Cancer
|
Below are MeSH descriptors whose meaning is more general than "Tumor Microenvironment".
Below are MeSH descriptors whose meaning is more specific than "Tumor Microenvironment".
This graph shows the total number of publications written about "Tumor Microenvironment" by people in this website by year, and whether "Tumor Microenvironment" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2010 | 0 | 2 | 2 |
2011 | 2 | 3 | 5 |
2012 | 4 | 2 | 6 |
2013 | 0 | 4 | 4 |
2014 | 4 | 4 | 8 |
2015 | 2 | 9 | 11 |
2016 | 9 | 9 | 18 |
2017 | 5 | 16 | 21 |
2018 | 6 | 14 | 20 |
2019 | 10 | 16 | 26 |
2020 | 17 | 23 | 40 |
2021 | 8 | 25 | 33 |
2022 | 4 | 41 | 45 |
2023 | 2 | 34 | 36 |
2024 | 11 | 20 | 31 |
2025 | 3 | 8 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Microenvironment" by people in Profiles.
-
HIV status alters immune cell infiltration and activation profile in women with breast cancer. Nat Commun. 2025 May 20; 16(1):4699.
-
Selective inhibition of canonical STAT3 signaling suppresses K-ras mutant lung tumorigenesis and reinvigorates anti-tumor immunity. Front Immunol. 2025; 16:1575181.
-
Metastatic medulloblastoma remodels the local leptomeningeal microenvironment to promote further metastatic colonization and growth. Nat Cell Biol. 2025 May; 27(5):863-874.
-
Tumor-derived arachidonic acid reprograms neutrophils to promote immune suppression and therapy resistance in triple-negative breast cancer. Immunity. 2025 Apr 08; 58(4):909-925.e7.
-
Artificial intelligence-based virtual staining platform for identifying tumor-associated macrophages from hematoxylin and eosin-stained images. Eur J Cancer. 2025 May 02; 220:115390.
-
High tumor CD161 expression predicts a survival advantage and marks a Th1-skewed microenvironment. Front Immunol. 2025; 16:1522755.
-
Leveraging space innovations for cancer breakthroughs on Earth. Trends Cancer. 2025 May; 11(5):433-440.
-
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy. Cell Oncol (Dordr). 2025 Jun; 48(3):559-590.
-
Tumor Immune Microenvironment Differences Associated With Racial Disparities in Pancreatic Cancer. J Surg Res. 2025 Mar; 307:21-32.
-
ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis. Cancer Res. 2025 Jan 15; 85(2):299-313.